NCT01732926 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 320
- group Id
- BG001
- value
- 155
- group Id
- BG002
- value
- 475
- units
- Participants
- groups
- description
- Idelalisib 150 mg tablet twice daily + bendamustine intravenously (starting dose of 90 mg/m\^2 for up to 12 infusions) + rituximab intravenously (375 mg/m\^2 on Day 1 for a total of 6 infusions)
- id
- BG000
- title
- Idelalisib + Bendamustine + Rituximab
- description
- Placebo tablet twice daily + bendamustine intravenously (starting dose of 90 mg/m\^2 for up to 12 infusions) + rituximab intravenously (375 mg/m\^2 on Day 1 for a total of 6 infusions)
- id
- BG001
- title
- Placebo + Bendamustine + Rituximab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.5
- value
- 62
- group Id
- BG001
- spread
- 11.1
- value
- 62
- group Id
- BG002
- spread
- 10.9
- value
- 62
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 190
- title
- Female
- measurements
- group Id
- BG000
- value
- 188
- group Id
- BG001
- value
- 97
- group Id
- BG002
- value
- 285
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 34
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 247
- group Id
- BG001
- value
- 122
- group Id
- BG002
- value
- 369
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 62
- title
- Not Permitted
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 24
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 262
- group Id
- BG001
- value
- 129
- group Id
- BG002
- value
- 391
- title
- Not Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 60
- title
- Not Permitted
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 27
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 49
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 53
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 32
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 47
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 66
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 19
- title
- Czech Republic
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Sweden
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- title
- Taiwan
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 36
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 12
- title
- Korea, Republic of
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 35
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 8
- title
- Israel
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- The Intent to Treat (ITT) Analysis Set: all participants who were randomized regardless of whether they received any study treatment
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 320
- group Id
- BG001
- value
- 155
- group Id
- BG002
- value
- 475
- units
- Participants
- groups
- description
- Idelalisib 150 mg tablet twice daily + bendamustine intravenously (starting dose of 90 mg/m\^2 for up to 12 infusions) + rituximab intravenously (375 mg/m\^2 on Day 1 for a total of 6 infusions)
- id
- BG000
- title
- Idelalisib + Bendamustine + Rituximab
- description
- Placebo tablet twice daily + bendamustine intravenously (starting dose of 90 mg/m\^2 for up to 12 infusions) + rituximab intravenously (375 mg/m\^2 on Day 1 for a total of 6 infusions)
- id
- BG001
- title
- Placebo + Bendamustine + Rituximab
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 10.5
- value
- 62
- group Id
- BG001
- spread
- 11.1
- value
- 62
- group Id
- BG002
- spread
- 10.9
- value
- 62
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 58
- group Id
- BG002
- value
- 190
- title
- Female
- measurements
- group Id
- BG000
- value
- 188
- group Id
- BG001
- value
- 97
- group Id
- BG002
- value
- 285
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 26
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 34
- title
- Asian
- categories
- measurements
- group Id
- BG000
- value
- 2
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 4
- title
- Black or African American
- categories
- measurements
- group Id
- BG000
- value
- 247
- group Id
- BG001
- value
- 122
- group Id
- BG002
- value
- 369
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 6
- title
- Other
- categories
- measurements
- group Id
- BG000
- value
- 41
- group Id
- BG001
- value
- 21
- group Id
- BG002
- value
- 62
- title
- Not Permitted
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 8
- group Id
- BG002
- value
- 24
- title
- Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 262
- group Id
- BG001
- value
- 129
- group Id
- BG002
- value
- 391
- title
- Not Hispanic or Latino
- categories
- measurements
- group Id
- BG000
- value
- 42
- group Id
- BG001
- value
- 18
- group Id
- BG002
- value
- 60
- title
- Not Permitted
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 16
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 27
- title
- Russian Federation
- categories
- measurements
- group Id
- BG000
- value
- 37
- group Id
- BG001
- value
- 12
- group Id
- BG002
- value
- 49
- title
- United States
- categories
- measurements
- group Id
- BG000
- value
- 33
- group Id
- BG001
- value
- 20
- group Id
- BG002
- value
- 53
- title
- United Kingdom
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 32
- title
- Spain
- categories
- measurements
- group Id
- BG000
- value
- 47
- group Id
- BG001
- value
- 19
- group Id
- BG002
- value
- 66
- title
- Canada
- categories
- measurements
- group Id
- BG000
- value
- 12
- group Id
- BG001
- value
- 7
- group Id
- BG002
- value
- 19
- title
- Czech Republic
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 5
- title
- Sweden
- categories
- measurements
- group Id
- BG000
- value
- 7
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 9
- title
- Taiwan
- categories
- measurements
- group Id
- BG000
- value
- 25
- group Id
- BG001
- value
- 11
- group Id
- BG002
- value
- 36
- title
- Poland
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 12
- title
- Korea, Republic of
- categories
- measurements
- group Id
- BG000
- value
- 21
- group Id
- BG001
- value
- 14
- group Id
- BG002
- value
- 35
- title
- Italy
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 2
- group Id
- BG002
- value
- 8
- title
- Israel
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Region of Enrollment
- unit Of Measure
- Participants
- population Description
- The Intent to Treat (ITT) Analysis Set: all participants who were randomized regardless of whether they received any study treatment
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle